In one of the first such studies involving human patients with schizophrenia, researchers at UC Davis have provided evidence that deficits in a brain chemical, the neurotransmitter gamma-aminobutyric acid, or GABA may be responsible for some of the debilitating cognitive deficits — poor attention, memory and problem-solving abilities — that accompany the delusions and hallucinations that are the hallmarks of the disorder.
The study is published online in the Journal of Neuroscience.
Link:http://www.eurekalert.org/pub_releases/2010-03/uoc--udr030410.php
Source:EurekAlert